Outwater Regulatory Consulting,
LLC is committed to providing timely, accurate and cost effective solutions to your project. Every client
is unique and deserves a focused approach to ensure their project needs are met on time and on budget.
"Bob joined the Thiakis team at a critical time to leverage our European
clinical trial approval to file our IND in a truly effective
manner. His approach to FDA regulatory affairs integrated well with our overall regulatory strategy and his contribution to
the team was invaluable."
Dr John Burt
Chief Executive Officer
Note: Wyeth Pharmaceuticals acquired Thiakis Limited in December